Iron Overload in Patients Undergoing Donor Stem Cell Transplant

Completed

Conditions studied: Cancer, Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation

In brief

RATIONALE: Learning about the effect of excess iron in the liver of patients undergoing donor stem cell transplant may help doctors plan treatment. PURPOSE: This study is investigating the effects of iron overload in patients undergoing donor stem cell transplant.

Key facts

Study ID

NCT00888316

Run by

Masonic Cancer Center, University of Minnesota

People needed

112

Starts

2008-12-01

Expected to finish

2012-06-01

Last updated by the study team

2017-12-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Planning to undergo allogeneic hematopoietic stem cell transplantation using either myeloablative or reduced-intensity conditioning
• Any diagnosis allowed
• Not pregnant
• Weight ≤ 350 lbs
• Must be able to give written informed consent indicating the investigational nature of the study and its potential risks.

You may not qualify if…

• Claustrophobia
• Other contraindication for MRI (e.g., cardiac pacemaker, implanted cardiac defibrillator, aneurysm clips, carotid artery vascular clamp, neurostimulator, insulin or infusion pump, or implanted drug infusion device)

Where it is running

• University of Minnesota Children's Hospital - Fairview — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.